Thiopurine Management
Genotypes a patient to aid in individualizing a starting dose of thiopurines. Ordering prior to initiating therapy provides information for effective dosing, which may achieve maximum efficacy with minimized toxicity.
Sample insurance correspondence for PROMETHEUS® TPMT Genetics
Prometheus Laboratories is certified under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high-complexity clinical laboratory testing and is accredited by the College of American Pathologists (CAP). Tasso+ is a FDA Class II Lancet 510(k)-cleared single-use blood lancing device intended for obtaining microliter capillary whole blood samples that is manufactured by Tasso, Inc. PredictrPK and Anser sample collection with the Tasso+ device is not yet available for New York State patients. This material is provided for general information purposes only as an educational service for healthcare physicians and their patients. It is not intended as a substitute for medical advice and/or consultation with a physician.